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Background: Malnutrition is frequently observed in patients with pulmonary tuberculosis (TB). The present study
aimed to examine the relationship between nutritional status using Malnutrition Universal Screening Tool (MUST)
and the mortality of patients with pulmonary TB.
Methods: Fifty-seven patients with pulmonary TB were analyzed. Nutrition assessment was carried out using MUST.
The Cox proportional hazard model was applied to assess the ability of MUST to predict prognosis. Receiver
operating characteristic curve analysis was used to assess MUST score as a prognostic indicator in pulmonary TB
patients. To obtain optimal cut-off values for MUST score for prognostic assessment in TB patients, we used the
maximum Youden Index.
Results: For predicting the risk of mortality, the optimal cut-off value for MUST score was 3.5. Univariate and
multivariate analyses identified age and MUST score ≥ 4 as significant independent prognostic factors for survival.
The patients with MUST score ≤ 3 had a median survival of 481 days (95% CI: 453 to 510) and that for the patients
with MUST score ≥ 4 was 304 days (95% CI: 214 to 394); the difference was statistically significant (P = 0.001).
Conclusion: MUST appears to be a reliable tool for nutritional risk assessment of patients with pulmonary TB. In
addition, MUST may be a useful prognostic indicator of survival in patients with pulmonary TB.Background
Tuberculosis (TB) has afflicted mankind from time imme-
morial. TB is also a reemerging infectious disease that was
declared a global public health problem by the World
Health Organization in 1993. In 2011, there were an esti-
mated 8.7 million new cases of TB (13% co-infected with
HIV) and 1.4 million people died from TB, including
almost one million deaths among HIV-negative individ-
uals and 430 000 among people who were HIV-positive.
TB is one of the top killers of women, with 300 000 deaths
among HIV-negative women and 200000 deaths among
HIV-positive women in 2011 [1].
In Japan, the TB incidence rate fell below 20 per 100,000
in 2007 and continued to decline, reaching 19.0 in 2009.* Correspondence: smiyata61@hotmail.com
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reproduction in any medium, provided the orHowever, 24,170 TB patients were newly identified in
2009. In 2009, TB incidence rates of elderly populations
aged 65–74, 75–84 and 85 or older were 26.5, 63.4 and
98.1 per 100,000 in Japan, respectively [2].
Aging of the population and the increased use of im-
munosuppressive treatments (e.g. cancer chemotherapy
and immunomodulatory agents) highlight the need for add-
itional strategies to maintain and improve TB control [3].
Malnutrition is frequently observed in patients with
pulmonary TB. Several studies reported that patients with
active pulmonary TB are malnourished, as indicated by
reductions in the level of visceral proteins, anthropometric
indexes and micronutrient status [4,5]. Nutrition support
is necessary for malnourished TB patients. Nutrition risk
assessment is important in providing nutrition support.
The Malnutrition Universal Screening Tool (MUST) is a
simple, quick, valid and reliable tool to identify patients
who are malnourished or at risk of malnutrition.
To the best of our knowledge, no studies have examined
the relationship between MUST and the mortality ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to examine the relationship between MUST and the prog-
nosis of patients with pulmonary TB.
Methods
Patients
Fifty-seven patients with pulmonary tuberculosis were
analyzed. This is a retrospective study. This study was
carried out in only one hospital (Hanna Hospital). The
diagnosis of pulmonary TB was made on the basis of
symptoms, chest radiographic infiltrates and the pre-
sence of M. tuberculosis on sputum culture. Patient age
ranged from 17 to 91 years (mean, 64.9 years). Patient
characteristics are summarized in Table 1. This study
was approved by the institutional review board. This
study was carried out in compliance with the Helsinki
Declaration.
Anti-tuberculosis therapy
All patients received anti-tuberculosis therapy. All patients
were in-patients at the start of anti-tuberculosis therapy.
The regimen comprised isoniazid, rifampicin, ethambutol
and pyrazinamide daily for two months, followed by
isoniazid and rifampicin daily for the next four months.
Dosage of anti-tuberculosis drugs by body weight is de-
scribed in Table 2. Pyrazinamide was not administered to
patients aged 80 years or older. The anti-tuberculosisTable 1 Characteristics of 57 patients with pulmonary
tuberculosis
Characteristics Values
Gender (male/female) 42 (73.7)/15 (26.3)
Age (years) 64.9 ± 20.1
Body mass index (kg/m2) 19.3 ± 2.8
Underlying disease
Malignant disease 3 (5.3)
Diabetes mellitus 8 (14.0)
Presence of hypoxemia on admission 4 (7.0)
Smear positive 50 (87.7)
Radiological findings




Total Protein (g/dL) 6.6 ± 1.0
Albumin (g/dL) 3 ± 0.8
Cholinesterase (U/L) 136.1 ± 77.2
Hemoglobin (g/dL) 12.0 ± 2.2
CRP (mg/dL) 6.6 ± 6.0
Data are presented as n (%) or mean ± SD.
TB: tuberculosis.therapy to patients aged 80 years or older was carried out
for nine months.
Nutrition assessment
The nutrition assessment was carried out using MUST.
MUST includes three variables: unintentional weight loss
score in the preceding 3 to 6 months (weight loss < 5% = 0,
weight loss 5–10% = 1, weight loss > 10% = 2), body mass
index (BMI) score (BMI >20.0 = 0, BMI 18.5–20.0 = 1,
BMI < 18.5 = 2) and acute disease effect score (Add a score
of 2 if there has been or is likely to be no nutritional intake
for >5 days). Each is scored on a scale of 0, 1 or 2 and their
sum categorizes the malnutrition risk as low (0), medium
(1) or high (≥ 2).
Statistical analysis
Results are expressed as mean ± standard deviation. The
Cox proportional hazard model was applied to assess
the ability of MUST to predict prognosis. Receiver oper-
ating characteristic (ROC) curve analysis was used to as-
sess MUST score as a prognostic indicator in pulmonary
TB patients. Follow up was measured from the date of
the first patient visit to the hospital until death or the
last date of observation. Minimum follow-up duration
was 90 days. The Kaplan-Meier method with the log-
rank test was used to calculate survival. P values <0.05
were considered to be statistically significant. Statistical
analysis was performed using SPSS 18.0 (SPSS, Inc., an
IBM Company, Chicago, IL, USA).
Results
Table 1 summarizes the demographic and baseline clinical
characteristics of the patients. There were 42 men and 15
women. The age ranged from 17 to 91 years (mean ± SD,
64.9 ± 20.1 years). Univariate and multivariate analyses
showed that age was a significant prognostic factor. In
contrast, high risk (MUST score ≥ 2) was not a significant
prognostic factor (Table 3). An ROC curve was generated
for further analysis of the prognostic value of MUST score,
as presented in Figure 1. The area under the curve (AUC)
was 0.772 (95% confidence interval 0.636–0.908). MUST
score was considered to have moderate prognostic accur-
acy. To obtain optimal cut-off values for MUST score for
prognostic assessment in TB patients, we used the max-











30 < BW ≤ 40 200 300 500 1200
40 < BW ≤ 55 300 450 750 1200
55 < BW 300 600 750 1500
BW, Body weight.
MUST: Malnutrition Universal Screening Tool.
Figure 1 Receiver operating characteristic (ROC) curve for MUST scor
interval 0.636–0.908).
Table 3 Univariate Cox proportional hazard regression
analyses associated with survival
Variables HR 95% CI P value
Gender (female) 3.119 0.900–10.804 0.073
Age (years) 1.105 1.023–1.192 0.011
Body mass index (kg/m2) 0.862 0.680–1.093 0.22
Underlying disease
Malignant disease 1.953 0.247–15.455 0.526
Diabetes mellitus 0.678 0.086–5.352 0.712
Presence of hypoxemia on admission 1.549 0.196–12.255 0.678
Smear positive 1.307 0.165–10.341 0.8
Radiological findings
bilateral involvement 1.809 0.384–8.526 0.454
cavitation 1.164 0.328–4.133 0.814
effusion 0.507 0.064–4.007 0.519
Laboratory findings
Total Protein (g/dL) 0.589 0.290–1.198 0.144
Albumin (g/dL) 0.41 0.176–0.954 0.038
Cholinesterase (U/L) 0.992 0.982–1.002 0.106
Hemoglobin (g/dL) 0.735 0.536–1.008 0.056
CRP (mg/dL) 1.094 0.996–1.201 0.061
MUST score≥ 2 4.401 0.557–34.742 0.16
MUST score≥ 4 14.747 1.860–116.265 0.011
HR: hazard ratio; CI: confidence interval; TB: tuberculosis; CRP:
C-reactive protein;
MUST: Malnutrition Universal Screening Tool.
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cut-off value for MUST score of 3.5, the sensitivity was
90.0% and the specificity was 68.1% for survival. Patients
were divided into two groups based on MUST score ≤ 3
or ≥ 4. On the basis of this cut-off value, the Cox propor-
tional hazard model was applied to assess the ability of
MUST score ≥ 4 to predict the prognosis of TB patients.
Univariate analysis showed that age, albumin and MUST
score ≥ 4 were significant prognostic factors (Table 3).
Multivariate analysis was performed with a forward step-
wise approach in age, albumin and MUST score ≥ 4.
Multivariate analysis identified age (HR = 1.088, 95% CI =
1.017–1.165, P = 0.015) and MUST score ≥ 4 (HR = 0.097,
95% CI =0.012–0.777, P = 0.028) as significant independ-
ent prognostic factors for survival (Table 4). Figure 2
shows the survival curves for the patients with MUST
score ≤ 3 and those with MUST score ≥ 4. The patients
with MUST score ≤ 3 had a median survival of 481 days
(95% CI: 453 to 510) and that for the patients with MUST
score ≥ 4 was 304 days (95% CI: 214 to 394); the difference
was statistically significant (P = 0.001). An HIV test was
performed in no patient. Four patients underwent intra-
venous hyper-alimentation and three patients underwent
respiratory management during the treatment.
Discussion
TB is often associated with nutritional deficiencies. A
study of 30 patients with pulmonary TB in England re-
vealed a reduction in BMI, triceps skin hold, arm musclee. Detailed legend: n = 57, AUC = 0.772 (95% confidence
Table 4 Multivariate Cox proportional hazard regression
analyses associated with survival
Variables HR 95% CI p-value
Age (years) 1.088 1.017–1.165 0.015
MUST score≥ 4 0.097 0.012–0.777 0.028
HR: hazard ratio; CI: confidence interval; MUST: Malnutrition Universal
Screening Tool.
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tuberculosis patients were respectively 11 and seven times
more likely to have a BMI < 18.5 and mid-arm circumfer-
ence < 24 cm [6].
The mortality rate among TB patients in Spain who
completed treatment was found to be associated with vul-
nerable populations such as the elderly, alcohol abusers
and HIV-infected injecting drug users [7]. We previously
reported that subjective global assessment was useful in
predicting the survival in patients with pulmonary tuber-
culosis [8]. In Japan, only 124 newly identified TB patients
were reported as having HIV in 2007–2008 [2]. It seems
that HIV infection does not have a large influence on the
mortality rate among TB patients in Japan.
Patients with TB very frequently suffer from deficiencies
of nutrients, such as vitamins A, B complex, C and E, as
well as selenium, which are fundamental to the integrity
of the immune response [9-11]. Three studies found lowerFigure 2 Survival curves for the patients with MUST score ≤ 3 and th
were those who reached the end of their follow up without dying. Log-ranlevels of serum vitamin D in TB patients compared with
those in controls [12-14]. Recently, Martineau et al.
reported that vitamin D did not significantly affect time to
sputum culture conversion in the whole study population,
but it did significantly hasten sputum culture conversion
in participants with the tt genotype of the TaqI vitamin D
receptor during intensive-phase antimicrobial treatment
of pulmonary tuberculosis [15]. In addition to the central
role of lipid storage, adipose tissue has major endocrine
functions and releases a variety of proinflammatory and
anti-inflammatory factors, including adipocytokines, such
as leptin, adiponectin and resistin, as well as cytokines and
chemokines. Altered levels of different adipocytokines
have been observed in a variety of inflammatory condi-
tions and, in particular, the role of leptin in immune re-
sponses and inflammation has lately become increasingly
evident [16]. Active tuberculosis is associated with cach-
exia, weight loss and low serum concentration of leptin
[17,18]. Moreover, leptin-deficient mice are more suscep-
tible to M. tuberculosis than wild-type mice, and T cell
numbers, including those producing IFN-γ, are reduced in
infected lungs, suggesting that leptin contributes to pro-
tection against tuberculosis [19]. However, a causative cor-
relation between the severity of TB and leptin has not
been fully established, and leptin concentrations do not
predict wasting in human TB [18]. Nutrition and infectione patients with MUST score ≥ 4. Detailed legend: Censored patients
k test, P = 0.001.
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tions lead to a loss of body nitrogen and worsen nutri-
tional status; the resulting malnutrition, in its turn,
produces a greater susceptibility to infection.
A number of nutrition screening tools have therefore
been developed. MUST is a well-validated and reliable
screening tool. Stratton et al. showed that MUST has
predictive validity in an elderly hospitalized population,
with regard to mortality, both in hospital and after
discharge, and length of hospital stay [20]. Harris et al.
reported that MUST was a sensitive and specific
method of identifying those requiring further nutritional
assessment in elderly people living in sheltered accom-
modation [21]. Recently, a cross-sectional study of the
nutritional status of community-dwelling people with
idiopathic Parkinson’s disease revealed the usefulness of
MUST as an early screening tool [22].
Adoption of a cut-off value of 3.5 improves the pre-
dictive ability of MUST score as a prognostic indicator
in pulmonary TB patients. MUST will be used in future
studies of nutrition support in TB patients. One of the
limitations in this study is the short duration of follow
up. Minimum follow-up duration was 90 days. Other
limitations of this study are the small sample size and
imbalance of male/female ratio. For these reasons, it
cannot be regarded as representative of the whole pul-
monary TB population.Conclusion
MUST appears to be a reliable tool for nutritional risk
assessment of patients with pulmonary TB. In addition,
MUST may be a useful prognostic indicator of survival
in patients with pulmonary TB.
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